SCHEMBL4961191

SCHEMBL4961191

CC1(C)CC(c2ccccc2N)Nc2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HTR5A P47898 4/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35
▸ BCHE P06276 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2139850 0.85 F7 (0.33) NPC1ALDH1A1MAPTRAB9AHTR5A
SCHEMBL2137370 0.84 PRKAB2 (0.38) HTR2AMAPTMEN1ALOX15CYP2C19
SCHEMBL2135630 0.81 F7 (0.37) ALDH1A1KMT2AKDM1A
SCHEMBL2135149 0.81 CTSD (0.35) HTR2AALDH1A1MAPTRAB9AMEN1
SCHEMBL2138126 0.80 PRKAB2 (0.47) KDM1A
SCHEMBL2137710 0.75 AR (0.42) ALDH1A1MAPTRAB9ACYP3A4MEN1
SCHEMBL7631876 0.74 KDM1A (0.41) HTR2AHTR5AKMT2AKDM1A
SCHEMBL7759529 0.72 BRD4 (0.44) ALDH1A1RAB9AHTR5AKDM1A
SCHEMBL9469119 0.69 AR (0.54) MAPTCYP3A4MEN1CYP2D6ALOX15
SCHEMBL2136187 0.67 PRKAB2 (0.38) HTR2AMAPTMEN1ALOX15CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896466-A1 N-LINKED HETEROCYCLIC ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS Bristol-Myers Squibb Company (US) 2008-03-12 — — EP disclosed
WO-2007002637-A1 N-LINKED HETEROCYCLIC ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-04 — — WO disclosed
Send feedback